CNX Therapeutics Limited (“CNX Therapeutics”) today announced the appointment of Peter Butterfield as Chief Operating Officer, effective February 19, 2025. Peter brings extensive pharmaceutical and ...
In a report released today, Gabriel Daoud from TD Cowen maintained a Buy rating on Civitas Resources (CIVI – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback